Results for Basic Science

1 - 10 of 229

Dr. George's basic and clinical research interests are in the development of novel therapeutics for hemophilia. Her basic science laboratory studies the molecular basis of coagulation, and she is the principal investigator of ongoing hemophilia A and B gene therapy trials.

E-mail:

georgel [at] chop.edu

David R. Lynch, MD, PhD

Dr. Lynch maintains a dynamic program that involves clinical, translational, and basic science research efforts focused on the rare disease Friedreich ataxia.

E-mail:

lynch [at] chop.edu

Hyun-Duck Nah-Cederquist, DMD, MSD, PhD

Dr. Nah-Cederquist investigates solutions to clinical problems in pediatric plastic surgery. Her lab is built around the strengths of CHOP's clinical practices and basic science research. This offers the unique opportunity to directly test hypotheses born from clinical problems in the laboratory, and to take new technologies and concepts developed in the laboratory to patient care.

E-mail:

nah [at] chop.edu

Patrick J. Cahill, MD

Dr. Cahill's focuses on improving treatments for patients with early onset chest and spinal deformity, employing a combination of clinical, biomechanical, and basic science research approaches.

E-mail:

cahillp1 [at] chop.edu

Jason P. Van Batavia, MD

Dr. Van Batavia's long-term goal is to become a leader in neuro-urology and lower urinary tract dysfunction, with particular emphasis on deciphering the pathophysiology of lower urinary tract dysfunction and translating developments in the basic science arena into clinical improvements for patients.

E-mail:

vanbataviaj [at] chop.edu

Gerd Blobel, MD, PhD

Dr. Blobel investigates the fundamental mechanisms involving transcription factors, chromatin regulators, and higher order chromatin. He is gearing his basic science discoveries towards genetic and epigenetic treatment modalities. In addition, Dr. Blobel is interested in mechanism of epigenetic memory.

E-mail:

blobel [at] chop.edu

John M. Maris, MD

Dr. Maris investigates the molecular and genetic mechanisms contributing to the development and progression of neuroblastoma, a common childhood cancer. He also aims to develop new molecular diagnostic tests and less toxic, targeted therapies to treat relapsed or refractory neuroblastoma, including a major effort in immunotherapy discovery and development.

E-mail:

maris [at] chop.edu

Bhavya Doshi, MD

Dr. Doshi is a pediatric hematologist who specializes in bleeding and clotting disorders. Her research focuses on hemophilia, alloantibody responses, and improving diagnostics for patients with bleeding disorders.

E-mail:

doshibs [at] chop.edu

Robert O. Heuckeroth, MD, PhD

Dr. Heuckeroth investigates mechanisms controlling bowel motility in order to find new ways to treat, diagnose, and prevent intestinal motility disorders. His research is focused on enteric nervous system and smooth muscle biology as he works to find new ways to improve the lives of children with bowel motility disorders.

E-mail:

heuckerothr [at] chop.edu

Stephan Kadauke, MD, PhD

Dr. Kadauke is the associate director of the Cell and Gene Therapy Laboratory at CHOP and the medical director of the Cell and Gene Therapy Informatics team. His research focuses on developing novel ways to manufacture cell therapies with the goal of accelerating and broadening patient access to these life-saving therapies.

E-mail:

kadaukes [at] chop.edu